GABRIELA OCASIO BULTRON: Open Payments
NPI 1538843834 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 12 payments from 8 companies in 2025. Trend: 2023 $81 · 2024 $447 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| PFIZER INC. | 1 | $20 |
| PhotoniCare Inc | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, EVENITY, PREVNAR 20, Wegovy, OtoSight Middle Ear Scope, TRELEGY ELLIPTA, QULIPTA, NUZYRA.
Industry payments across FL — which companies pay providers there.
